Ray Dalio Stock Portfolio: Top 15 Stock Picks

Published on February 14, 2023 at 12:31 pm by Ramish Cheema in Hedge Funds, News

In this piece, we will take a look at Ray Dalio Stock Portfolio: Top 15 Stock Picks. For more stocks, head on over to Ray Dalio Stock Portfolio: Top 5 Stock Picks.

Ray Dalio’s Bridgewater Associates is one of the biggest investment management firms in the world. In fact, as of December 2022, the firm had a whopping $18 billion in its portfolio invested in the stock market, and if you thought this was huge, then you’d be surprised to learn that the total assets management by Bridgewater Associates stood at $126 billion during the same time period according to data from Pensions and Investments. This made Bridgewater one of the biggest hedge funds in the world and marked a strong 20% annual growth at a time when investor confidence in the stock market was low. Conversely, this growth during a turbulent time also shows confidence in Mr. Dalio and his firm, as investors were more confident about investing their money with Bridgewater when the broader market was underperforming.

Naturally, the scope of its hedge fund and his accomplishments have also made Mr. Dalio a towering individual in the finance industry. He is also always willing to share his life experiences and management philosophy, not only having authored a book but also being present on Twitter where he shares tips daily for anyone willing to learn. One bit of advice that he recently shared tells viewers to take a look at themselves as part of a bigger picture and understand that an objective analysis will always yield the best results. In his own words:

You are expected to go to the higher level and look down on yourself and others as part of a system. In other words, you must get out of your own head, consider your views as just some among many, and look down on the full array of points of view to assess them in an idea-meritocratic way rather than just in your own possessive way. Seeing things from the higher level isn’t just seeing other people’s point of view; it’s also being able to see every situation, yourself, and others in the situation as though you were looking down on them as an objective observer.If you can do this well, you will see the situation as “another one of those,” see it through everyone’s eyes, and have good mental maps or principles for deciding how to handle it.

Additionally, the billionaire former hedge fund boss also believes that the Federal Reserve’s interest rate hiking cycle which started last year will now usher in a new paradigm for the economy, where growth will be slower than desired and inflation will be higher than most would prefer. In fact, he believes that the era of borrowing funds to make long term bets might be over, as he shared advice on making the right bets this year in a recent LinkedIn post and outlined that:

As for what seem to be the good and bad bets, it appears to me that the big power countries that are plagued with the big problems that I described, and the world as a whole, are in what I call Stage 5 of the Big Cycle—i.e., near the brinks of financial/economic crises and big internal conflicts/wars, and in the early part of an evolving, costly climate crisis—at the same time as the world is near the brink of having amazing technological breakthroughs that will affect our daily lives. Stage 5 is the last-chance stage before going into Stage 6 which is the financial crisis and war part of the cycle. It seems to me that that will make the environment very challenging for those who are following the traditional leveraged long approach to investing in traditional areas, while it will provide great opportunities in those geographic and subject areas that are benefiting from these changes.

Whether it’s life or investment, Ray Dalio is a guru, and while he stepped down as the fund’s co-chief investment officer late last year, Bridgewater’s bets as the new year starts are still worth looking at. Some companies that it has piled into are PepsiCo, Inc. (NASDAQ:PEP), Johnson & Johnson (NYSE:JNJ), and The Procter & Gamble Company (NYSE:PG).

Our Methodology

We sifted through Bridgewater Associates’ filing with the SEC for the fourth quarter of last year to determine which companies it has invested in. Out of these, the top fifteen are listed down. To see how the hedge fund’s investment approach evolved over the quarter, you can also look at Billionaire Ray Dalio’s Bridgewater Associates 13F Portfolio: Top 10 Stock Picks, which lists down the investments for Q3 2022.

Ray Dalio Stock Portfolio: Top 15 Stock Picks

15. Pfizer Inc. (NYSE:PFE)

Bridgewater Associates’ Q4 2022 Stake: $140 million

Number of Hedge Fund Holders in Q3 2022: 77

Pfizer Inc. (NYSE:PFE) is a pharmaceutical giant headquartered in New York, New York. The firm researches for, develops and sells medicines and vaccines. It also offers its manufacturing facilities to other companies to make drugs.

Bridgewater Associates held a $140 million stake in Pfizer Inc. (NYSE:PFE) by the end of December 2022, which came through 2.7 million shares. The firm is currently aggressively marketing its coronavirus treatment Paxlovid, as sales are dropping. By the end of last year’s third quarter, 77 of the 920 hedge funds polled by Insider Monkey had invested in Pfizer Inc. (NYSE:PFE).

Pfizer Inc. (NYSE:PFE)’s largest investor is Cliff Asness’ AQR Capital Management which owns 10.6 million shares that are worth $467 million.

14. Colgate-Palmolive Company (NYSE:CL)

Bridgewater Associates’ Q4 2022 Stake: $149 million

Number of Hedge Fund Holders in Q3 2022: 57

Colgate-Palmolive Company (NYSE:CL) is an American consumer goods company that sells different products such as toothpaste, shampoos, deodorants, and dental care pharmaceuticals. The firm is based in New York, New York.

Colgate-Palmolive Company (NYSE:CL) was left red faced in February 2023 after it recalled its Fabuloso multi purpose cleaner due to a risk of bacterial infection. Mr. Dalio’s hedge fund held a $149 million stake in the company in Q4 2022 as it owned 1.8 million shares, and in the prior quarter, 57 of the 920 hedge funds surveyed by Insider Monkey had invested in the company.

Dan Loeb’s Third Point is Colgate-Palmolive Company (NYSE:CL)’s largest investor. It owns 11.5 million shares that are worth $811 million.

13. Visa Inc. (NYSE:V)

Bridgewater Associates’ Q4 2022 Stake: $174 million

Number of Hedge Fund Holders in Q3 2022: 165

Visa Inc. (NYSE:V) is a payments platform products and services company that provides banks with debit and credit cards for consumer use and merchant with a platform to collect payments. It is based in San Francisco, California.

Bridgewater Associates owned 838,784 Visa Inc. (NYSE:V) shares for a $174 million investment in 2022’s final quarter. While other companies are laying off employees, the firm actually plans to hire more as it opened an office in Atlanta in February 2023. 165 of the 920 hedge funds part of Insider Monkey’s September quarter of 2022 survey also held a stake in Visa Inc. (NYSE:V).

Out of these, Visa Inc. (NYSE:V)’s largest investor is Chris Hohn’s TCI Fund Management which owns 19 million shares that are worth $4 billion.

12. Mondelez International, Inc. (NASDAQ:MDLZ)

Bridgewater Associates’ Q4 2022 Stake: $192 million

Number of Hedge Fund Holders in Q3 2022: 52

Mondelez International, Inc. (NASDAQ:MDLZ) is a food and beverage company operating out of Chicago, Illinois. The firm sells snacks, powdered beverages, and other products.

Mondelez International, Inc. (NASDAQ:MDLZ) is currently investing heavily in making wheat farming sustainable in Europe, as the commodity forms a major component of its products. Bridgewater Associates held a $192 million stake in the firm in Q4 2022, through owning 2.8 million shares.

Insider Monkey dug through 920 hedge fund portfolios for last year’s third quarter to discover that 52 had invested in Mondelez International, Inc. (NASDAQ:MDLZ).

Mondelez International, Inc. (NASDAQ:MDLZ)’s largest shareholder is Josh Overdeck and David Siegel’s John Overdeck And David Siegel which owns 4 million shares that are worth $220 million.

11. Abbott Laboratories (NYSE:ABT)

Bridgewater Associates’ Q4 2022 Stake: $243 million

Number of Hedge Fund Holders in Q3 2022: 62

Abbott Laboratories (NYSE:ABT) is a diversified healthcare company that makes and sells medicines, nutrition products, and medical devices. The firm is based in North Chicago, Illinois.

Abbott Laboratories (NYSE:ABT)’s problems with last year’s infant formula shortage in the U.S. continue to cause headaches as the Justice Department is investigating the company in a probe whose nature is unclear. 62 of the 920 hedge funds polled by Insider Monkey had invested in the firm during September 2022.

Ray Dalio’s Bridgewater Associates owns 2.2 million Abbott Laboratories (NYSE:ABT) shares for a $243 million stake.

Abbott Laboratories (NYSE:ABT)’s largest investor is Ken Fisher’s Fisher Asset Management which owns 9.3 million shares that are worth $1 billion.

Vulcan Value Partners mentioned the firm in its Q4 2022 investor letter, outlining that:

“Abbott Laboratories (NYSE:ABT) is one of the largest and most diversified health care companies in the world. It operates in four segments: diagnostics, medical devices, nutritional products and established pharmaceuticals. The company quickly established itself as a global leader in the development and deployment of COVID-19 rapid diagnostic tests. Consequently, its revenue and profit growth accelerated during the pandemic. As demand for testing slowed to a more sustainable level, the company is facing difficult earnings comparisons. In addition, Abbott voluntarily recalled certain infant formula products and shut down a plant in Michigan where the products were manufactured, which put more pressure on its earnings comparisons. The plant has resumed production, and Abbott is regaining lost market share. We believe that these events, one positive and one negative, have distorted Abbott’s sustainable earning power and has given us an opportunity to purchase it with a margin of safety.”

10. CVS Health Corporation (NYSE:CVS)

Bridgewater Associates’ Q4 2022 Stake: $255 million

Number of Hedge Fund Holders in Q3 2022: 67

CVS Health Corporation (NYSE:CVS) is a health services provider that lets customers take out health insurance, pharmacies manage their networks, and regular people buy prescription and over the counter drugs.

CVS Health Corporation (NYSE:CVS) is busy diversifying its business model away from insurance as it announced in February 2023 that it will buy a primary healthcare provider for a whopping $9.5 billion. By the end of September 2022, 67 of the 920 hedge funds polled by Insider Monkey had invested in the company, and Ray Dalio’s hedge fund held a $255 million stake at the close of the year.

CVS Health Corporation (NYSE:CVS)’s largest investor is Cliff Asness’ AQR Capital Management which owns 3.8 million shares that are worth $365 million.

9. Starbucks Corporation (NASDAQ:SBUX)

Bridgewater Associates’ Q4 2022 Stake: $259 million

Number of Hedge Fund Holders in Q3 2022: 54

Starbucks Corporation (NASDAQ:SBUX) is a specialty coffee retailer with thousands of stores all over the globe. It is headquartered in Seattle, Washington.

Starbucks Corporation (NASDAQ:SBUX) is currently facing a lot of controversies, as the National Labor Relations Board ordered the company to stop targeting baristas in favor of unionizing in February 2023. 54 of the 920 hedge funds polled by Insider Monkey in Q3 2022 had invested in the company.

In the following quarter, Bridgewater Associates owned 2.6 million Starbucks Corporation (NASDAQ:SBUX) shares that were worth $259 million.

Ken Fisher’s Fisher Asset Management is Starbucks Corporation (NASDAQ:SBUX)’s largest investor. It owns 10 million shares that are worth $1 billion.

8. Pinduoduo Inc. (NASDAQ:PDD)

Bridgewater Associates’ Q4 2022 Stake: $297 million

Number of Hedge Fund Holders in Q3 2022: 54

Pinduoduo Inc. (NASDAQ:PDD) is a Chinese internet retailer that sells a wide variety of products such as toys, appliances, apparel, shoes, and food and beverages.

Pinduoduo Inc. (NASDAQ:PDD) caught attention in February 2023 as it became a rare Chinese company to buy an advertisement during the Super Bowl. By the end of December 2022, Mr. Dalio’s hedge fund had held a $297 million stake in the company via 3.6 million shares, while in Q3 2022, 54 of the 920 hedge fund portfolios part of Insider Monkey’s research had held a stake in Pinduoduo Inc. (NASDAQ:PDD).

After Bridgewater, Jim Simons’ Renaissance Technologies is Pinduoduo Inc. (NASDAQ:PDD)’s largest investor. It owns 3.3 million shares that are worth $274 million.

7. McDonald’s Corporation (NYSE:MCD)

Bridgewater Associates’ Q4 2022 Stake: $416 million

Number of Hedge Fund Holders in Q3 2022: 53

McDonald’s Corporation (NYSE:MCD) is one of the world’s most famous and largest fast food chains. It has tens of thousands of restaurants all over the world.

Cashing in on the recent hype around artificial intelligence, McDonald’s Corporation (NYSE:MCD) is also implementing an automated AI based ordering system in its restaurants. Bridgewater Associates’ Q4 2022 stake in the company was worth $416 million and it came through 1.5 million shares.

By the end of last year’s third quarter, 53 of the 920 hedge funds part of Insider Monkey’s study had held McDonald’s Corporation (NYSE:MCD)’s shares.

McDonald’s Corporation (NYSE:MCD)’s second largest largest investor in our database is Jim Simons’ Renaissance Technologies which owns one million shares that are worth $288 million.

6. Costco Wholesale Corporation (NASDAQ:COST)

Bridgewater Associates’ Q4 2022 Stake: $427 million

Number of Hedge Fund Holders in Q3 2022: 69

Costco Wholesale Corporation (NASDAQ:COST) is a discount store company headquartered in Isaquah, Washington. The firm has a global operational footprint, with stores in the U.K., Puerto Rico, Taiwan, China, Australia, and other countries.

Costco Wholesale Corporation (NASDAQ:COST) faced a minor legal setback in February 2023 when it was ordered by a California court to pay $1.7 million to an aggrieved customer after the company failed to adequately accommodate her disabilities. Insider Monkey took a look at 920 hedge fund holdings for 2022’s September quarter to find out that 69 had invested in the firm.

Ray Dalio’s Bridgewater associates had invested $427 million in Costco Wholesale Corporation (NASDAQ:COST) during the fourth quarter of 2022, as it owned 937,521 shares of the company.

Costco Wholesale Corporation (NASDAQ:COST)’s largest investor is Ken Fisher’s Fisher Asset Management which owns 2.5 million shares that are worth $1.1 billion.

Madison Investment Management mentioned the company in its Q4 2022 investor letter as it outlined that:

“Costco Wholesale Corporation (NASDAQ:COST) stock fell after November sales results showed a slowing consumer. The slower November sales were followed by a slight first quarter miss with lower-than-expected margins. Costco commented that they are not seeing trade-down but private label penetration has increased modestly. Traffic continues to be positive, and Costco remains well-positioned in a more challenging macro environment due to its strong value proposition.”

PepsiCo, Inc. (NASDAQ:PEP), Costco Wholesale Corporation (NASDAQ:COST), Johnson & Johnson (NYSE:JNJ), and The Procter & Gamble Company (NYSE:PG) are some of Ray Dalio’s top stock picks.

Click to continue reading and see Ray Dalio Stock Portfolio: Top 5 Stock Picks.

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on June 23, 2025 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

The AI infrastructure supercycle
The onshoring boom driven by Trump-era tariffs
A surge in U.S. LNG exports
And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

Access to our Detailed Report on our AI, Tariffs, and Nuclear Energy Stock with 100+% potential upside within 12 to 24 months
BONUS REPORT on our #1 AI-Robotics Stock with 10000% upside potential: Our in-depth report dives deep into our #1 AI/robotics stock’s groundbreaking technology and massive growth potential.
One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
Bonus Content: Premium access to members-only fund manager video interviews
Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.
30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

A New Dawn is Coming to U.S. Stocks

Published on June 13, 2025 at by Insider Monkey Staff

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up

Ray Dalio Stock Portfolio: Top 15 Stock Picks

Published on February 14, 2023 at 12:31 pm by Ramish Cheema in Hedge Funds, News

Ray Dalio Stock Portfolio: Top 15 Stock Picks

15. Pfizer Inc. (NYSE:PFE)

14. Colgate-Palmolive Company (NYSE:CL)

13. Visa Inc. (NYSE:V)

12. Mondelez International, Inc. (NASDAQ:MDLZ)

11. Abbott Laboratories (NYSE:ABT)

10. CVS Health Corporation (NYSE:CVS)

9. Starbucks Corporation (NASDAQ:SBUX)

8. Pinduoduo Inc. (NASDAQ:PDD)

7. McDonald’s Corporation (NYSE:MCD)

6. Costco Wholesale Corporation (NASDAQ:COST)

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on June 23, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

A New Dawn is Coming to U.S. Stocks

Published on June 13, 2025 at by Insider Monkey Staff

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Premium

Log In

Sign Up

Ray Dalio Stock Portfolio: Top 15 Stock Picks

Published on February 14, 2023 at 12:31 pm by Ramish Cheema in Hedge Funds, News

Share

Ray Dalio Stock Portfolio: Top 15 Stock Picks

15. Pfizer Inc. (NYSE:PFE)

14. Colgate-Palmolive Company (NYSE:CL)

13. Visa Inc. (NYSE:V)

12. Mondelez International, Inc. (NASDAQ:MDLZ)

11. Abbott Laboratories (NYSE:ABT)

10. CVS Health Corporation (NYSE:CVS)

9. Starbucks Corporation (NASDAQ:SBUX)

8. Pinduoduo Inc. (NASDAQ:PDD)

7. McDonald’s Corporation (NYSE:MCD)

6. Costco Wholesale Corporation (NASDAQ:COST)

Share

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on June 23, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

A New Dawn is Coming to U.S. Stocks

Published on June 13, 2025 at by Insider Monkey Staff